|
KIAA0430 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.73538960979158E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.6886053079761E-11 |
| Normal-vs-Stage2 |
2.00679999995401E-06 |
| Normal-vs-Stage3 |
3.23260307411033E-11 |
| Normal-vs-Stage4 |
9.39579525294221E-11 |
| Stage1-vs-Stage2 |
9.775800E-01 |
| Stage1-vs-Stage3 |
1.312810E-01 |
| Stage1-vs-Stage4 |
1.739570E-02 |
| Stage2-vs-Stage3 |
2.894400E-01 |
| Stage2-vs-Stage4 |
8.566500E-02 |
| Stage3-vs-Stage4 |
4.154400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.32338584535319E-13 |
| Normal-vs-AfricanAmerican |
1.382340E-03 |
| Normal-vs-Asian |
9.85849999968202E-07 |
| Caucasian-vs-AfricanAmerican |
2.832600E-01 |
| Caucasian-vs-Asian |
3.156200E-01 |
| AfricanAmerican-vs-Asian |
7.791000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.13139974955834E-10 |
| Normal-vs-Female |
2.04203320919305E-12 |
| Male-vs-Female |
8.569600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.3622997415489E-10 |
| Normal-vs-Age(41-60Yrs) |
5.99229554865133E-11 |
| Normal-vs-Age(61-80Yrs) |
1.97210026087191E-10 |
| Normal-vs-Age(81-100Yrs) |
3.970800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.591800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.185400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.337200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.092800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.617000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.724200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.785600E-04 |
| Classical-VS-Follicular |
5.967500E-02 |
| Classical-VS-Other |
2.902600E-01 |
| Classical-VS-Normal |
1.23710000021759E-07 |
| Tall-VS-Follicular |
1.575400E-01 |
| Tall-VS-Other |
7.689400E-01 |
| Tall-VS-Normal |
6.02240479707916E-11 |
| Follicular-VS-Other |
7.956800E-01 |
| Follicular-VS-Normal |
4.62469995632375E-09 |
| Other-VS-Normal |
3.860800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.79829492910721E-11 |
| Normal-vs-N1 |
1.97939997725882E-10 |
| N0-vs-N1 |
1.193430E-01 |
|
|
